Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1998
|
| gptkbp:ATCCode |
B01AC16
|
| gptkbp:CASNumber |
188627-80-7
|
| gptkbp:contraindication |
active internal bleeding
history of stroke |
| gptkbp:eliminationHalfLife |
2.5 hours
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:genericName |
eptifibatide
|
| gptkbp:hasMolecularFormula |
C35H49N11O9S2
|
| https://www.w3.org/2000/01/rdf-schema#label |
Integrilin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
glycoprotein IIb/IIIa inhibitor
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
25%
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
bleeding
thrombocytopenia |
| gptkbp:usedFor |
gptkb:acute_coronary_syndrome
percutaneous coronary intervention |
| gptkbp:bfsParent |
gptkb:Schering-Plough
|
| gptkbp:bfsLayer |
7
|